Moderna, Inc. (MRNA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 122.69 |
| Open | 120.75 |
| Bid | 117.27 x 400 |
| Ask | 117.38 x 400 |
| Day's range | 116.73 - 124.90 |
| 52-week range | 62.55 - 142.79 |
| Volume | |
| Avg. volume | 3,874,138 |
| Market cap | 44.958B |
| Beta (5Y monthly) | 1.57 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -15.59 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 138.52 |
Yahoo FinanceNovavax stock doubles after Sanofi deal marks 'new chapter' for company
Novavax stock popped Friday on news of a licensing deal and minority stake from Big Pharma player Sanofi.
Investor's Business DailyModerna Tumbles After The FDA Throws A Curveball On Its Second Product
Moderna stock toppled Friday after the FDA delayed an approval decision on its RSV vaccine until the end of the month.
Barrons.comFDA Delays Decision on Moderna RSV Shot by 3 Weeks
The agency was originally scheduled to announce its call on Sunday. The company said it hadn’t flagged any issues with the drug’s safety, efficacy, or quality.
© 2024 Yahoo. All rights reserved.